Aspirin at very ultra low dosage in healthy volunteers: effects on bleeding time, platelet aggregation and coagulation
Author(s):, , ,
Journal/Book: Haemostasis. 1990; 20: 99-105.
Abstract: Aspirin at very ultra low dosage was tested in healthy volunteers (n = 20) in a randomized, double-blind and placebo-controlled trial. The results showed a bleeding time reduction (p < 0.05) in volunteers having previously ingested aspirin. Platelet aggregation on platelet-rich plasma was not statistically modified after aspirin ingestion. Thrombin clotting time was always higher (p < 0.05) in the treaded group.